Clinical Trials
13 trialsNCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed
NCT03283488 2023-07-07
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
University of Sao Paulo
Phase 2 Completed
NCT00866970 2020-07-09
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
CSL Behring
Phase 2 Completed
NCT01433263 2016-03-02
Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas
Novartis
Phase 2 Completed
NCT02350855 2015-01-30
Impact of Nutritional Intervention in Indian Female Cancer Cachexia Patients
University of Westminster
Phase 2 Completed
NCT01238107 2014-09-10
A Clinical Study With MT-102 in Subjects With Cancer Cachexia
Akamis Bio
Phase 2 Completed
NCT00467844 2014-07-11
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
GTx
Phase 2 Completed
NCT00066248 2014-02-03
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
University of South Florida
Phase 2 Completed
NCT00219817 2013-09-02
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed
NCT00527319 2013-01-30
VT-122
Vicus Therapeutics
Phase 2 Completed
NCT00004912 2012-05-30
Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss
Northwestern University
Phase 2 Completed
NCT00895726 2012-01-13
Pilot Study of APD209 in Cancer Cachexia
Acacia Pharma Ltd
Phase 2 Completed
NCT00060502 2011-05-17
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Centocor, Inc.
Phase 2 Completed